Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Marpai, Inc.

Ticker
MRAI
Sector
Industry
Report date
November 15, 2026
Valye AI Score

96

Very high visibility
Recent developments
Recent developments summary

Recent news coverage includes business-related articles and transcripts from other companies' earnings calls, with limited direct news on Marpai. Past coverage highlights expense reductions and insider purchases.

Recent developments:
  • Marpai reported cutting losses as expenses dropped by 70%, indicating cost management efforts. [N13]
  • The CEO of Marpai purchased 86,805 shares, signaling insider confidence. [N14]
  • Marpai reported quarterly earnings results in March 2025 and Q3 2024 financial results were published. [N15]
  • Recent news primarily covers broader market topics such as commodity price movements and unrelated earnings call transcripts. [N1][N2][N3][N4][N5][N6][N7][N8]
Overview

Marpai, Inc. is a U.S.-based technology platform company specializing in healthcare administration services for self-insured employers. It operates subsidiaries providing Third Party Administrator (TPA) services, Pharmacy Benefit Management (PBM), and value-oriented health plan services. The company’s clients are mainly small and medium-sized enterprises and local government entities that self-insure employee health benefits. Marpai designs and manages healthcare plans for clients, providing access to provider networks, claims adjudication, care management, and pharmacy savings programs. The company does not assume claims risk, which remains with the clients and stop-loss insurers. Marpai uses proprietary technology including deep learning and data analytics to engage members proactively and reduce healthcare costs. The company operates in a highly regulated environment with extensive federal and state healthcare laws. Competition is intense, with many regional and national players in the fragmented TPA market. Financial disclosures show modest revenue with net losses and liquidity constraints as of the latest quarter.

Executive summary

Marpai, Inc. operates as a technology platform providing Third Party Administrator (TPA), Pharmacy Benefit Management (PBM), and health plan services to self-insured employers, primarily SMEs and local governments in the U.S. The company’s business model centers on administering healthcare plans without bearing claims risk, generating revenue from administration, ancillary services, and third-party vendor fees. Marpai leverages deep learning and data analytics to improve healthcare outcomes and reduce costs. The healthcare market for self-insured employers is large and fragmented, with increasing adoption of self-funded plans. Marpai faces competition from large insurers and many regional TPAs. The company is subject to extensive healthcare regulations including fraud, privacy, and managed care laws. Financially, as of September 30, 2026, Marpai reported $4.42 million in quarterly revenue and a net loss of $3.29 million, with limited liquidity (current ratio 0.65). Revenues are concentrated among a few customers. The company is currently reviewing strategic alternatives. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for MRAI

Bull case model:

Marpai leverages advanced technology and data analytics to address the growing demand for cost containment and improved outcomes in the self-insured employer healthcare market. Its integrated service offerings and proactive member engagement could enhance client satisfaction and retention. The company’s focus on SMEs and local governments taps into a large and expanding market segment adopting self-funded plans. Strategic alternatives under review may unlock additional value or operational efficiencies. Continued innovation in care management and pharmacy benefit programs could further reduce costs and improve member health outcomes.

Bear case model:

Marpai operates in a highly competitive and fragmented market with significant pressure from large insurers and numerous regional TPAs. The company’s revenues are concentrated among a few customers, posing risks if major clients terminate agreements. Limited liquidity and ongoing net losses highlight financial challenges. Regulatory compliance risks are substantial given the complex healthcare laws and potential penalties for non-compliance. The strategic alternatives review introduces uncertainty and potential disruption. Market shifts away from self-insurance or increased competition could reduce addressable market size and profitability.

Moat:

Marpai’s moat is based on its proprietary technology platform that integrates deep learning and data analytics to deliver cost-effective healthcare administration and proactive member engagement. Its focus on self-insured SMEs and local governments, combined with a comprehensive suite of services including TPA, PBM, and ancillary care management, differentiates it from smaller regional TPAs. The company’s partnerships with major provider networks and its ability to negotiate significant savings on out-of-network claims and specialty pharmacy costs add value for clients. However, the TPA market is highly fragmented and competitive, with large insurers and many regional providers vying for business. Marpai’s moat depends on maintaining technological differentiation, client retention, and navigating complex regulatory requirements effectively.

Risks overview
Risks summary
Customer concentration and regulatory compliance represent significant risks, compounded by financial constraints and competitive pressures.
Risks details:

• Customer Concentration Risk: A few major customers account for a significant portion of revenue and accounts receivable. Loss of these customers or failure to perform could materially reduce revenue.
• Financial and Liquidity Risk: The company reported net losses and has a current ratio below 1, indicating potential liquidity constraints that could impact operations.
• Regulatory Compliance Risk: Marpai is subject to extensive federal and state healthcare regulations including fraud and abuse laws, privacy laws, and managed care regulations. Non-compliance could result in penalties and operational restrictions.
• Competitive Risk: The TPA market is highly fragmented and competitive, with large insurers and many regional providers competing for clients. Maintaining technological differentiation and client retention is critical.
• Strategic Alternatives Uncertainty: The ongoing review of strategic alternatives may incur costs and create uncertainty that could disrupt business operations and affect stockholder value.

FINAL FORECAST FOR MRAI

Final take one line
Marpai, Inc. operates a technology-driven healthcare administration platform focused on self-insured employers, with detailed disclosures and financial data providing very high visibility into its business model and risks.
Final take 12 to 24 month view

Business trends: Increasing adoption of self-funded health plans among SMEs and growing demand for technology-enabled cost containment in healthcare administration.
Execution milestones: Ongoing strategic alternatives review, continued development of proprietary analytics and care management services, and client retention efforts.
Key risks: Customer concentration, regulatory compliance challenges, financial liquidity constraints, competitive pressures, and uncertainty from strategic alternatives process.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

96
LLM visibility overview
LLM Visibility known facts
  • Marpai, Inc. is a technology platform company operating subsidiaries that provide Third Party Administrator (TPA), Pharmacy Benefit Management (PBM), and value-oriented health plan services to self-insured employers in the U.S. [S1]
  • The company’s clients are primarily small and medium-sized enterprises (SMEs) and local government entities that self-insure employee health benefits. [S1]
  • Marpai’s business model involves administering healthcare plans for clients without bearing financial risk for claims; the risk is borne by the self-insured clients and stop-loss insurers if applicable. [S1]
  • Revenue is derived from Health Plan Administration services, In-House Ancillary services (such as clinical care management, claims repricing, pharmacy savings programs), and Third-Party Vendor services. [S1]
  • The company uses deep learning and data analytics to improve healthcare outcomes and reduce costs, including proactive member engagement and a mobile app for members. [S1]
  • The healthcare market for self-insured employers is large and fragmented, with increasing adoption of self-funded plans among SMEs. [S1]
  • Marpai faces competition from large health insurers and numerous regional and specialty TPA providers. [S1]
  • The company is subject to extensive federal and state healthcare regulations, including fraud and abuse laws, privacy and data security laws (HIPAA, HITECH), and managed care laws. [S1]
  • As of September 30, 2026, Marpai reported $4.42 million in revenue and a net loss of $3.29 million for the quarter. [S2]
  • At the same date, cash and equivalents were $360,000, current assets $10.37 million, current liabilities $15.86 million, resulting in a current ratio of 0.65 and a cash ratio of 0.02. [S2]
  • The company’s earnings per share basic and diluted were both -$0.13 for the quarter ended September 30, 2026. [S2]
  • Marpai’s revenues are concentrated with a few major customers, with one customer accounting for 13.6% of accounts receivable as of September 30, 2026. [S2]
  • The company is reviewing strategic alternatives, which may involve costs and uncertainties impacting business operations and stockholder value. [S2]
Sources
Sources - Context summary

Generated 2026-11-15

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-25 | 10-K
  • S2 | 2026-11-12 | 10-Q
Sources - News headlines
  • N1 | 2026-11-15 | www.nasdaq.com | Soybeans Post Friday Gains Following Export Announcements | https://www.nasdaq.com/articles/soybeans-post-friday-gains-following-export-announcements
  • N2 | 2026-11-15 | www.nasdaq.com | Hogs Post Gains Across the Board on Friday | https://www.nasdaq.com/articles/hogs-post-gains-across-board-friday
  • N3 | 2026-11-15 | www.nasdaq.com | Soybeans Popping Higher on Friday Following Export Announcements | https://www.nasdaq.com/articles/soybeans-popping-higher-friday-following-export-announcements
  • N4 | 2026-11-15 | www.nasdaq.com | Accelevation (ACCV) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/accelevation-accv-q3-2026-earnings-call-transcript
  • N5 | 2026-11-15 | www.nasdaq.com | Katapult (KPLT) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/katapult-kplt-q3-2026-earnings-call-transcript
  • N6 | 2026-11-15 | www.nasdaq.com | OpenWorld (OPNW) Q4 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/openworld-opnw-q4-2026-earnings-call-transcript
  • N7 | 2026-11-15 | www.nasdaq.com | Thinking of Leaving Your Job in 2027? Here's How It Could Cost You Your 401(k) Match. | https://www.nasdaq.com/articles/thinking-leaving-your-job-2027-heres-how-it-could-cost-you-your-401k-match
  • N8 | 2026-11-15 | www.nasdaq.com | Cattle Close the Week with a Rally | https://www.nasdaq.com/articles/cattle-close-week-rally
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine